anastrozole has been researched along with Lung Diseases, Interstitial in 1 studies
Lung Diseases, Interstitial: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
| Excerpt | Relevance | Reference |
|---|---|---|
| "An 83‒year‒old woman received trastuzumab plus anastrozole as first‒line chemotherapy for inflammatory breast cancer in her left breast." | 8.02 | [Case Report of an Elderly Patient with Interstitial Pneumonia Caused by the Administration of Trastuzumab plus Anastrozole for the Treatment of Inflammatory Breast Cancer]. ( Aizu, K; Fujieda, H; Furuta, M; Iwata, T; Kageyama, Y; Kobayashi, S; Sato, F; Toyoda, Y; Watanabe, S; Yamaguchi, R, 2021) |
| "An 83‒year‒old woman received trastuzumab plus anastrozole as first‒line chemotherapy for inflammatory breast cancer in her left breast." | 4.02 | [Case Report of an Elderly Patient with Interstitial Pneumonia Caused by the Administration of Trastuzumab plus Anastrozole for the Treatment of Inflammatory Breast Cancer]. ( Aizu, K; Fujieda, H; Furuta, M; Iwata, T; Kageyama, Y; Kobayashi, S; Sato, F; Toyoda, Y; Watanabe, S; Yamaguchi, R, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iwata, T | 1 |
| Yamaguchi, R | 1 |
| Furuta, M | 1 |
| Watanabe, S | 1 |
| Aizu, K | 1 |
| Kobayashi, S | 1 |
| Sato, F | 1 |
| Fujieda, H | 1 |
| Toyoda, Y | 1 |
| Kageyama, Y | 1 |
1 other study available for anastrozole and Lung Diseases, Interstitial
| Article | Year |
|---|---|
[Case Report of an Elderly Patient with Interstitial Pneumonia Caused by the Administration of Trastuzumab plus Anastrozole for the Treatment of Inflammatory Breast Cancer].
Topics: Aged, 80 and over; Anastrozole; Female; Humans; Inflammatory Breast Neoplasms; Lung Diseases, Inters | 2021 |